FOXO TECHNOLOGIES INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
FOXO TECHNOLOGIES INC. (FOXO) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $256.00 thousand as of 2024-03-31, per its 10-Q filed 2024-06-28.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2024-06-28
- 2024-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $256.00K.
- 2023-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $256.00K.
- 2023-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $256.00K.
- 2023-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $256.00K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net |
|---|---|
| 2024-03-31 | $256.00K 10-Q · filed 2024-06-28 |
| 2023-12-31 | $256.00K 10-K · filed 2024-06-06 |
| 2023-09-30 | $256.00K 10-Q/A · filed 2024-06-04 |
| 2023-06-30 | $256.00K 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |